Contravisory Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,763
| Closed | -$52K | – | 324 |
|
2022
Q3 | $52K | Buy |
1,763
+31
| +2% | +$914 | 0.02% | 240 |
|
2022
Q2 | $94K | Sell |
1,732
-16
| -0.9% | -$868 | 0.03% | 218 |
|
2022
Q1 | $95K | Buy |
+1,748
| New | +$95K | 0.03% | 222 |
|
2020
Q3 | – | Sell |
-1,439
| Closed | -$74K | – | 266 |
|
2020
Q2 | $74K | Sell |
1,439
-28
| -2% | -$1.44K | 0.03% | 192 |
|
2020
Q1 | $69K | Buy |
1,467
+425
| +41% | +$20K | 0.03% | 201 |
|
2019
Q4 | $61K | Sell |
1,042
-15
| -1% | -$878 | 0.02% | 218 |
|
2019
Q3 | $56K | Buy |
1,057
+28
| +3% | +$1.48K | 0.02% | 224 |
|
2019
Q2 | $51K | Hold |
1,029
| – | – | 0.02% | 224 |
|
2019
Q1 | $54K | Hold |
1,029
| – | – | 0.02% | 209 |
|
2018
Q4 | $49K | Buy |
+1,029
| New | +$49K | 0.02% | 202 |
|
2018
Q1 | – | Sell |
-14
| Closed | -$1K | – | 382 |
|
2017
Q4 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 365 |
|